Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKYA
3051
DELISTED
Akoya BioSciences
AKYA
| $653K | ﹤0.01% |
46,766
-3,756
| -7% | -$62.8K |
|
|
LENZ
3052
LENZ Therapeutics
LENZ
$163M
| $653K | ﹤0.01% |
+5,685
| New | +$842K |
|
3053
Cardiff Oncology
CRDF
$81.7M
| $652K | ﹤0.01% |
97,763
+12,146
| +14% | +$76.3K |
|
3054
FS Bancorp
FSBW
$323M
| $652K | ﹤0.01% |
18,824
| – | – |
|
3055
Mastech Digital
MHH
$94.5M
| $651K | ﹤0.01% |
38,217
| – | – |
|
|
PCSB
3056
DELISTED
PCSB Financial Corporation
PCSB
| $650K | ﹤0.01% |
35,225
| – | – |
|
3057
Neurogene
NGNE
$714M
| $641K | ﹤0.01% |
4,430
| – | – |
|
|
SYRS
3058
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $639K | ﹤0.01% |
14,279
-24,901
| -64% | -$1.22M |
|
|
GTYH
3059
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $639K | ﹤0.01% |
84,870
-202,574
| -70% | -$1.45M |
|
3060
VirnetX Holding Corp
VHC
$61.4M
| $636K | ﹤0.01% |
8,110
-14,112
| -64% | -$1.15M |
|
|
CBAY
3061
DELISTED
Cymabay Therapeutics
CBAY
| $635K | ﹤0.01% |
173,959
-357,375
| -67% | -$1.41M |
|
|
MTEM
3062
DELISTED
Molecular Templates, Inc.
MTEM
| $628K | ﹤0.01% |
6,239
-11,800
| -65% | -$1.22M |
|
|
ATNX
3063
DELISTED
Athenex, Inc. Common Stock
ATNX
| $626K | ﹤0.01% |
10,384
-16,211
| -61% | -$1.18M |
|
3064
Noble Corp
NE
$7.1B
| $620K | ﹤0.01% |
+22,896
| New | +$548K |
|
|
EMWP
3065
DELISTED
Eros Media World PLC
EMWP
| $620K | ﹤0.01% |
33,678
| – | – |
|
3066
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $618K | ﹤0.01% |
7,061
-18
| -0.3% | -$1.58K |
|
|
ONIT
3067
Onity Group
ONIT
$328M
| $617K | ﹤0.01% |
21,925
-33,149
| -60% | -$916K |
|
|
PSTL
3068
Postal Realty Trust
PSTL
$680M
| $614K | ﹤0.01% |
32,909
+3,183
| +11% | +$61K |
|
3069
Caesarstone
CSTE
$104M
| $612K | ﹤0.01% |
49,252
+2,185
| +5% | +$29.3K |
|
3070
Lifecore Biomedical
LFCR
$183M
| $612K | ﹤0.01% |
66,364
-111,531
| -63% | -$1.21M |
|
3071
Smith Micro Software
SMSI
$16.6M
| $612K | ﹤0.01% |
3,159
+451
| +17% | +$91.2K |
|
3072
Powell Industries
POWL
$7.59B
| $607K | ﹤0.01% |
74,076
-111,984
| -60% | -$1.01M |
|
3073
Vera Bradley
VRA
$95M
| $607K | ﹤0.01% |
64,427
-97,702
| -60% | -$1.07M |
|
3074
InfuSystem Holdings
INFU
$248M
| $606K | ﹤0.01% |
46,433
+1,266
| +3% | +$20.6K |
|
3075
Dianthus Therapeutics
DNTH
$6.07B
| $605K | ﹤0.01% |
5,191
+517
| +11% | +$60.2K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.